- Creators of next-gen graphene-enhanced technology
- Developers of Intellectual Property for practical applications
- Pursuers of better products for people and the environment
Why invest in ZEN?
- Actively commercializing our existing graphene-based product IP in the personal protective equipment and air filtration markets
- Pursuing a potential graphene-based antibiotic, antiviral, and antifungal compound that could be a potential medical breakthrough treatment for human-contracted pathogens
- Vertical integration strategy focused on development of graphene production capacity, supply agreements and our 100% owned Albany Pure™ Graphite deposit
- Building our IP Portfolio by developing partnerships and securing new IP in high-growth areas like advanced materials, clean tech, green energy and healthcare solutions
- Experienced business-oriented management team that is invested into the company
- Extensive government support for research and development
Company name: ZEN Graphene Solutions Ltd.
Traded on: TSX Venture Exchange
Stock symbol: ZEN
Irwin Lowy Barristers & Solicitors LLP
217 W. Queen Street #401
Toronto ON M5V 0R2
Capital Transfer Agency Inc.
390 Bay Street, Suite 920,
Toronto, ON, M5H 2Y2, Canada
Tel: (416) 350.5007
Fax: (416) 350.5008
2021 Request of Mailing Card (TBA)